Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew M. Oh currently holds 6,000 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew M. Oh has been a net neutral trader of SYRS stock. They have purchased $0 and sold $0 worth of shares.
Andrew M. Oh's most recent insider trade was on Jun 5, 2024, when they sold 6,000 shares at $0.00 per share.
Andrew M. Oh serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Andrew M. Oh holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew M. Oh has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew M. Oh was on May 15, 2020, when they sold $23.7K worth of RUBY shares. This transaction involved 5,000 shares at $4.74 per share.
Andrew M. Oh currently owns 6,000 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew M. Oh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew M. Oh has 5 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Andrew M. Oh and 40,000+ other insiders.